RxDoctor Payments Data

Thomas Higgins, MD

Orthopaedic Surgery · Salt Lake City, UTNPI 1376598615

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,048,703 of the $1,212,823 with a category attached, or 86.5%. Depuy Synthes Products, Inc. accounts for 86.5% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $377,156, 6.0 times the $63,049 reported in 2019. Among orthopaedic surgery clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,212,823in general payments, 2019–2025

Across 160 payments — averaging $7580.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$1M
  • Medical Device Business Services, Inc.$96K
  • Globus Medical$27K
  • Synthes GmbH$23K
  • Synthes USA Products LLC$13K
  • Osteocentric Technologies, Inc.$5K
  • plus $639 from 3 others
$352,037in ownership & investment interests, 2019–2025

Across 7 payments — averaging $50,291 each. An ownership or investment interest held by the physician or an immediate family member.

  • Osteocentric Technologies, Inc.$352K

What the payments were for

  • Royalty or licence$1,048,70386%
  • Consulting fees$126,82010%
  • Speaking & faculty fees$14,5001%
  • Travel & lodging$20,4672%
  • Food & beverage$2,3330%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,212,823 in reported general payments places this provider in the 95th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$60,981
Medicare patients
92
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →